Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantifying synergism/antagonism using nonlinear mixed-effects modeling: a simulation study.

John C Boik1, Robert A Newman, Robert J Boik

  • 1Graduate School of Biomedical Sciences, University of Texas, Houston, TX, U.S.A. jcboik@stanford.edu

Statistics in Medicine
|September 5, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AMPHIBIAN PARASITES EXHIBIT IDIOSYNCRATIC RELATIONSHIPS WITH SPATIOTEMPORAL ENVIRONMENTAL AND HOST-COMMUNITY VARIATION.

The Journal of parasitology·2025
Same author

Botanical oleander extract and oleandrin have superior effects on innate immune functions pertaining to dermal allergic reactions in canine cells when compared to oclacitinib.

American journal of veterinary research·2024
Same author

PBI-05204, a supercritical CO<sub>2</sub> extract of Nerium oleander, suppresses glioblastoma stem cells by inhibiting GRP78 and inducing programmed necroptotic cell death.

Neoplasia (New York, N.Y.)·2024
Same author

Preliminary investigation of the safe dose of oleandrin when administered orally to Beagles.

Journal of the American Veterinary Medical Association·2024
Same author

Oleander attenuates hepatic inflammation in a TLR4-independent manner and by favorable modulation of hepatocellular global metabolome that supports cytoprotection.

Journal of ethnopharmacology·2024
Same author

Differential Activities of the Botanical Extract PBI-05204 and Oleandrin on Innate Immune Functions under Viral Challenge Versus Inflammatory Culture Conditions.

Molecules (Basel, Switzerland)·2023
Same journal

Predictor-Assisted Nonparametric Graphical Models With Multivariate Error-Prone Data.

Statistics in medicine·2026
Same journal

Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.

Statistics in medicine·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
See all related articles

The new MixLow method accurately assesses cancer drug interactions using the Loewe additivity index and nonlinear mixed-effects models. It offers more precise parameter estimation and reliable confidence intervals compared to existing methods.

Area of Science:

  • Pharmacology
  • Biostatistics
  • Computational Biology

Background:

  • Cancer drugs are often given as combinations, necessitating methods to evaluate drug interactions.
  • Existing methods for assessing drug synergy or antagonism rely on various additive models.
  • Accurate quantification of drug interactions is crucial for optimizing cancer therapy.

Purpose of the Study:

  • To introduce and validate the MixLow method for quantifying drug interactions in cancer research.
  • To compare the performance of the MixLow method against the established Median-Effect method.
  • To provide a robust statistical framework for analyzing fixed-ratio drug combinations.

Main Methods:

  • Utilized the Loewe additivity index as the basis for interaction assessment.

Related Experiment Videos

  • Employed nonlinear mixed-effects models for estimating concentration-response curve parameters.
  • Developed a procedure for calculating confidence intervals for the interaction index, termed the MixLow method.

    • Main Results:

    • The MixLow method demonstrated more precise parameter estimation than the Median-Effect method in simulations.
    • Confidence interval coverage was acceptable for MixLow but poor for the Median-Effect method.
    • Analysis of a vincristine and topotecan mixture validated the MixLow method's applicability.

    Conclusions:

    • The MixLow method offers a statistically sound approach for analyzing drug interactions in fixed-ratio combinations.
    • It provides improved precision and reliability in quantifying synergistic and antagonistic effects.
    • This method is suitable for studies with sigmoidal dose-response patterns and replicates.